Need for Improved Access to Cancer Screening Tools for Minorities with Socioeconomic Barriers to Medical Care

Conference Correspondent  - ASCO 2021 - Breast Cancer

Health disparities may occur as the result of intersecting racial, ethnic, social, or financial barriers, which result in inequitable access to and distribution of medical care. Researchers investigated the relationship between socioeconomic disparities and cancer rates in populations where financial hardship creates gaps in access to medical care.

Among the 436,198 survey respondents, there was 9.8% cancer prevalence. A high occurrence of cancer was found in women and patients aged ≥70 years. Race and income levels were associated with statistically significant differences in frequency of cancer. Being Hispanic (19%) or multiracial (14%), or having an annual income <$25,000 (19%) were associated with increased prevalence and delayed access to cancer screening and treatment due to cost. The financial burden experienced by certain populations hinders access to recommended screenings such as breast cancer (17%), colon cancer (12%), and prostate cancer (11%).

The researchers concluded that socioeconomic status contributes to delayed access to appropriate cancer screenings and related medical care, especially in minority populations, which drives healthcare gaps for certain cancers. To address these gaps, improved access to cancer screening tools is necessary.

Source: Soror N, Keruakous A. Socio-economic disparities and accessibility to age-appropriate screening tools. American Society of Clinical Oncology Virtual Meeting; June 4-8, 2021. Abstract 1529.

Related Items
Inflammatory Responses to Neoadjuvant Chemotherapy Can Be Regulated by Moderate Physical Exercise Prior to Surgery
Conference Correspondent  published on June 7, 2021 in ASCO 2021 - Breast Cancer
Assessment of Factors That Influence Psychosocial Function in Breast Cancer Patients After Treatment
Conference Correspondent  published on June 7, 2021 in ASCO 2021 - Breast Cancer
Identification of Biomarkers for HER2-Negative Advanced Breast Cancer Is Influenced by Race: A Real-World Study
Conference Correspondent  published on June 7, 2021 in ASCO 2021 - Breast Cancer
Treatment with Alpelisib plus Fulvestrant Achieves Long-Term Disease Control in Endocrine-Resistant (HR-Positive/HER2-Negative) Advanced Breast Cancer
Conference Correspondent  published on June 7, 2021 in ASCO 2021 - Breast Cancer
Behavioral Interventions Demonstrate Improved Long-Term Adherence to Adjuvant Endocrine Therapy Among Women with HR-Positive Breast Cancer
Conference Correspondent  published on June 7, 2021 in ASCO 2021 - Breast Cancer
Assessment of Oncology Patient Satisfaction with Telehealth Visits
Conference Correspondent  published on June 7, 2021 in ASCO 2021 - Breast Cancer
Novel and Clinically Relevant Measure of Perceived Fatigability Reveals Benefit of Exercise in Breast Cancer Survivors
Conference Correspondent  published on June 7, 2021 in ASCO 2021 - Breast Cancer
Association of Stage of Breast Cancer Diagnosis and Socioeconomic Status in French Women
Conference Correspondent  published on June 7, 2021 in ASCO 2021 - Breast Cancer
Alpelisib Overcomes Resistance to CDK4/6 Inhibitors in HR-Positive/HER2-Negative Advanced Breast Cancer Patients
Conference Correspondent  published on June 7, 2021 in ASCO 2021 - Breast Cancer
Demographic and Clinical Factors Among Women with Breast Cancer Create a Gap Between Referrals and Completion of Genetic Counseling and Testing
Conference Correspondent  published on June 4, 2021 in ASCO 2021 - Breast Cancer
Copyright © Green Hill Healthcare Communications, LLC. All rights reserved.